Our approach to research
No research without therapeutic or policy benefit
Our teams are passionate, collaborative, innovative thinkers committed to excellence and on-time delivery.
We provide the full range of CRO services with effective differences: We incorporate behavioral sciences and digital strategies to strengthen trial design and execution, for faster bench to market results.
We focus on research with impact. We are a full service CRO with specialized capabilities in rare, orphan and underserved diseases, which are often considered hard to research.
Learn more about NERI's offerings for trials and registries from start-up through study closeout.
09/09/16: The latest issue of NERI's News & Views is now available for download in our Newsroom.
October 23, 2017
Vulvovaginal Atrophy Questionnaire (VVAQ) Poster Receives Top Poster Prize at 2017 North American Menopause Society Meeting
October 5, 2017
Anthem, HealthCore and Boehringer Ingelheim Initiate World’s Largest Pragmatic Clinical Trial to Study People Living with COPD in a Real-World Setting
September 12, 2017
HealthCore acquisition of NERI strengthens pre-approval and special populations research